Citi Pharma (KAR:CPHL) Probability of Financial Distress (%)

View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma Probability of Financial Distress (%)?

Citi Pharma does not have enough data to calculate Probability of Financial Distress (%).

Citi Pharma Probability of Financial Distress (%) Historical Data

The historical data trend for Citi Pharma's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma Probability of Financial Distress (%) Chart

Citi Pharma Annual Data

Trend

Probability of Financial Distress (%)

Citi Pharma Semi-Annual Data

Probability of Financial Distress (%)

Competitive Comparison of Citi Pharma's Probability of Financial Distress (%)

For the Drug Manufacturers - Specialty & Generic subindustry, Citi Pharma's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citi Pharma's Probability of Financial Distress (%) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citi Pharma's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Citi Pharma's Probability of Financial Distress (%) falls into.

Save Embed

;

Save Embed

;

Citi Pharma (KAR:CPHL) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.

Citi Pharma Probability of Financial Distress (%) Related Terms

Thank you for viewing the detailed overview of Citi Pharma's Probability of Financial Distress (%) provided by GuruFocus.com. Please click on the following links to see related term pages.

Citi Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Probability of Financial Distress (%)

Comparable Companies

Traded in Other Exchanges

N/A

Address

588 Q Block, Johar Town, Lahore, PB, PAK

Website

http://www.citipharma.com.pk

Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines